{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:13:46Z","timestamp":1784754826793,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.diagmicrobio.2018.03.017","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T07:42:56Z","timestamp":1523000576000},"page":"54-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosing candidemia with the T2Candida panel: an instructive case of septic shock in which blood cultures were negative"],"prefix":"10.1016","volume":"93","author":[{"given":"Cornelius J.","family":"Clancy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0005","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0010","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/650454","article-title":"Risk factors and outcomes of fungal ventricular-assist device infections","volume":"50","author":"Aslam","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/JCM.01602-10","article-title":"PCR diagnosis of invasive candidiasis: systematic review and meta-analysis","volume":"49","author":"Avni","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-135-6-200109180-00010","article-title":"Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial","volume":"135","author":"Boogaerts","year":"2001","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0030","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \"missing 50%\" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1586\/14787210.2014.919853","article-title":"Undiagnosed invasive candidiasis: incorporating non-culture diagnostics into rational prophylactic and preemptive antifungal strategies","volume":"12","author":"Clancy","year":"2014","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.diagmicrobio.2018.03.017_bb0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-4939-3052-4_16","article-title":"Diagnostic methods for detection of blood-borne candidiasis","volume":"1356","author":"Clancy","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.diagmicrobio.2018.03.017_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix1095","article-title":"Detecting Infections Rapidly and Easily for Candidemia Trial-2 (DIRECT2): a prospective, multicenter study of the T2Candida panel","author":"Clancy","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0050","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3201\/eid2111.150404","article-title":"Uncommon Candida species fungemia among cancer patients, Houston, Texas, USA","volume":"21","author":"Jung","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0035-1562891","article-title":"Complications of candidemia in ICU patients: endophthalmitis, osteomyelitis, endocarditis","volume":"36","author":"Kauffman","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0060","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","article-title":"Usefulness of the \"Candida score\" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study","volume":"37","author":"Leon","year":"2009","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0065","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diagmicrobio.2006.03.013","article-title":"The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients","volume":"55","author":"Magill","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0070","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/cid\/ciu959","article-title":"T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial","volume":"60","author":"Mylonakis","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0075","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3109\/23744235.2015.1028100","article-title":"Incidence and mortality of sepsis, severe sepsis, and septic shock in intensive care unit patients with candidemia","volume":"47","author":"Ng","year":"2015","journal-title":"Infect Dis (Lond)"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","article-title":"Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting","volume":"26","author":"Ostrosky-Zeichner","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2018.03.017_bb0085","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/ciu074","article-title":"MSG-01: A Randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting","volume":"58","author":"Ostrosky-Zeichner","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijantimicag.2011.02.016","article-title":"Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008\u20132009)","volume":"38","author":"Pfaller","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0095","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciw610","article-title":"Problematic dichotomization of risk for intensive care unit (ICU)\u2013acquired invasive candidiasis: results using a risk-predictive model to categorize 3 levels of risk from a multicenter prospective cohort of Australian ICU patients","volume":"63","author":"Playford","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0100","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0105","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1086\/509640","article-title":"Candidemia in patients with ventricular assist devices","volume":"44","author":"Shoham","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0110","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2215\/CJN.01610309","article-title":"Clinical outcomes of dialysis catheter-related candidemia in hemodialysis patients","volume":"4","author":"Sychev","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"15","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0115","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2016.14655","article-title":"Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial","volume":"316","author":"Timsit","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0120","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.diagmicrobio.2018.03.017_bb0130","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931830110X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931830110X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T07:07:40Z","timestamp":1553929660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288931830110X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S073288931830110X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.03.017","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosing candidemia with the T2Candida panel: an instructive case of septic shock in which blood cultures were negative","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}